Does the cardioprotective effect of Empagliflozin involve inhibition of the sodium-proton exchanger?
Cardiovasc Res
.
2021 Dec 17;117(14):2696-2698.
doi: 10.1093/cvr/cvab137.
Authors
Elizabeth Murphy
1
,
David A Eisner
2
Affiliations
1
National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.
2
Unit of Cardiac Physiology Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
PMID:
34021316
PMCID:
PMC8848318
DOI:
10.1093/cvr/cvab137
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzhydryl Compounds / pharmacology
Glucosides / pharmacology
Protons*
Sodium*
Substances
Benzhydryl Compounds
Glucosides
Protons
Sodium
empagliflozin